Armistice Capital, LLC Reports 9.99% Passive Stake in GeoVax Labs, Inc. (GOVX)

On May 15, 2026, Armistice Capital, LLC and its managing member, Steven Boyd, filed a Schedule 13G/A regarding their holdings in GeoVax Labs, Inc. (GOVX). The filing reports that the reporting persons beneficially own 291,155 shares of common stock, representing a 9.99% ownership stake in the company. This position is held directly by Armistice Capital Master Fund Ltd., for which Armistice Capital, LLC serves as the investment manager. The filing indicates an increase in holdings from a previously reported 0.0% to the current 9.99% level. Armistice Capital and Steven Boyd share voting and dispositive power over these shares. The securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer. The event triggering this specific filing occurred on March 31, 2026. This amendment (Amendment No. 3) confirms the significant passive investment position maintained by the New York-based investment firm in the biotechnology company.